The disposition of intramuscular artemether in children with cerebral malaria; A preliminary study

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 3, 1997, Pages 331-334

  Murphy, S A ^a,c,d,e   Mberu, E ^b   Muhia, D ^b   English, M ^a,c   Crawley, J ^a,c   Waruiru, C ^a   Lowe, B ^a,c   Newton, C R J ^a,c   Winstanley, P ^a,d   Marsh, K ^a,c   Watkins, W M ^a,b,d  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Artemether; Chemotherapy; Children; Kenya; Malaria; Pharmacokinetics; Plasmodium falciparum

Indexed keywords

ARTEMETHER; DIHYDROARTEMISININ;

ANTIMALARIAL ACTIVITY; ARTICLE; BIOASSAY; BRAIN MALARIA; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIVIDUALITY; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RESPIRATORY DISTRESS;

PLASMODIUM FALCIPARUM;

EID: 12644318782     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90097-3     Document Type: Article

References (18)

1. Alvan, G., Ekman, L. & Lindstrom, B. (1982). Determination of chloroquine and its metabolite in plasma, red blood cells and urine by liquid chromatography. Journal of Chromatography, 229, 241-247.
2. Edwards, G. (1994). Measurement of artemisinin and its derivatives in biological fluids. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, supplement 1, 137-139.
3. Hanks, G., Cassell, M., Ray, R. & Chaplin, H. (1960). Further modification of the benzidine method for the measurement of haemoglobin in plasma: definition of a new normal range. Journal of Laboratory and Clinical Medicine, 56, 486-498.
4. Hien, T. T. & White, N. J. (1993). Qinghaosu. Lancet, 341, 603-608.
5. Marsh, K., Forster, D., Waruiru, C., Mwangi, I., Winstanley, M., Marsh, V., Newton, C., Winstanley, P., Warn, P., Peshu, N., Pasvol, G. & Snow, R. (1995). Indicators of life-threatening malaria in African children. New England Journal of Medicine, 332, 1399-1404.
6. Muhia, D., Mberu, E. & Watkins, W. (1994a). Differential extraction of artemether and its metabolite dihydroartemisinin from plasma and determination by high-performance liquid chromatography. Journal of Chromatography, 660, 196-199.
7. Muhia, D., Thomas, C., Ward, S., Edwards, G., Mberu, E. & Watkins,W. (1994b). Ferriprotoporphyrin catalysed decomposition of artemether: analytical and pharmacological implications. Biochemical Pharmacology, 48, 889-895.
8. Murphy, S., English, M., Waruiru, C., Mwangi, I., Amukoye, E., Crawley, J., Newton, C., Winstanley, P., Peshu, N. & Marsh, K. (1996). An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 298-301.
9. Na-Bangchang, K., Karbwang, J., Thomas, C., Thanvibull, A., Sukontason, K., Ward, S. A. & Edwards, G. (1994). Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria. British Journal of Clinical Pharmacology, 37, 249-253.
10. Rieckmann, K., Campbell, G., Sax, L. & Mrema, J. (1978). Drug sensitivity of Plasmodium falciparum. An in vitro micro technique. Lancet, i, 22-23.
11. Taylor, T., Wills, B. A., Kazembie, P., Chisale, M., Wirima, J. J., Ratsma, E. Y. E. C. & Molyneux, M. E. (1993). Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet, 341, 661-662.
12. Thomas, C. G. & Ward, S. A. (1992). Selective determination, in plasma, of artemether and its metabolite, dihydroartemisinin, by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography, 583, 131-136.
13. Tutle, C. B. (1977). Intramuscular injections and bioavailability. American Journal of Hospital Pharmacy, 34, 965-968.
14. Van Hensbroek, M. B., Onyiorah, E., Jaffar, S., Schneider, G., Palmer, A., Frenkel, J., Enwere, G., Forck, S., Nusmeijer, A., Bennett, S., Greenwood, B. & Kwiatkowski, D. (1996). A trial of artemether or quinine in children with cerebral malaria. New England Journal of Medicine, 335, 69-75.
15. Walker, O., Salako, L. A., Omokhodion, S. I. & Sowunmi, A. (1993). An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 564-566.
16. Watkins, W. M., Chulay, J. D., Sixsmith, D. G., Spencer, H. C. & Howells, R. E. (1987). A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil. Journal of Pharmacy and Pharmacology, 39, 261-265.
17. Winstanley, P., Watkins, W., Newton, C., Nevill, C., Mberu, E., Warn, P., Waruiru, C., Mwangi, I., Warrell, D. & Marsh, K. (1992). The disposition of oral and intramuscular pyrimethamine/sulfadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. British Journal of Clinical Pharmacology, 33, 143-148.
18. Winstanley, P., Newton, C., Watkins, W., Mberu, E., Ward, S., Warn, P., Mwangi, I., Waruiru, C., Pasvol, G., Warrell, D. & Marsh, K. (1993). Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 201-206.